Women taking semaglutide, the active ingredient in Ozempic, are reporting menstrual irregularities, changes in bleeding ...

Rising healthcare costs are one of the biggest challenges facing Massachusetts communities. As WAMC reports, weight loss ...

Some adults in the Coachella Valley may qualify for GLP-1 weight loss drugs through a recently launched Medicare program. Medicare launched a temporary GLP-1 Bridge Program on July 1, which allows ...

There’s a lot to consider before starting or stopping a GLP-1 medication. This wellness retreat lays it all on the table.

Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI‑driven Internet healthcare solutions, announced the launch of Kyinsu®, the world's first once-weekly basal ...

The biggest healthcare savings from GenAI won’t come from cutting clinicians, but from preventing complications and improving ...

What happens when an expensive drug that works well for a condition affecting millions of people remains out of reach to many ...

Medicare’s new Part D program is aiming to cover certain GLP-1 medications for people with obesity, potentially lowering costs for eligible patients (with a co-pay mentioned around $50/month). In this ...

A study on over 800k adults with type 2 diabetes found that semaglutide and other GLP-1 drugs did not increase or decrease ...

The advent of an immunotherapy to delay type 1 diabetes and more potential treatments in the pipeline have shifted the way ...

Adding a GLP-1 receptor agonist was not associated with a lower likelihood of discontinuing existing basal insulin therapy ...

Poison control calls involving semaglutide (Ozempic and Wegovy) soared after the drug was approved for weight management, ...